Maarten Cozijnsen

48 19. Rheenen PF. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control. Inflamm Bowel Dis 2012;18:2018-2025. 20. Nakarl I, Focht G, Church P, et al. Associations among mucosal and transmural healing and fecal level of calprotectin in children with Crohn’s disease. Clin Gastroenterol Hepatol 2018;16:1089- 1097. 21. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-1321. 22. Cozijnsen MA, van Pieterson M, Samsom JN, et al. Top-down Infliximab Study in Kids with Crohn’s disease (TISKids): an international multicentre randomised controlled trial. BMJ Open Gastroenterol 2016;3:e000123. 23. Turner D, Griffiths AM, Walters TD, et al. Mathematical weighting of the pediatric Crohn’s disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis 2012;18:55- 62. 24. Minderhoud I, Steyerberg E, van Bodegraven A, et al. Predicting Endoscopic Disease Activity in Crohn’s Disease: A New and Validated Noninvasive Disease Activity Index (The Utrecht Activity Index). Inflamm Bowel Dis 2015;21:2453-2459. 25. Reinisch W, Panaccione R, Bossuyt P, et al. OP015 Biomarker correlation with endoscopic outcomes in patients with Crohn’s disease: data from CALM. Abstr 13th Congr ECCO February 2018. 26. Daniluk U, Daniluk J, Krasnodebska M, et al. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn’s disease. Adv Med Sci 2018;64:9- 14. 27. Feinstein A. An additional basic science for clinical medicine: IV. The development of clinimetrics. Ann Intern Med 1983;99:843-848. 28. Feinstein A. “Clinical Judgment” revisited: the distraction of quantitative models. Ann Intern Med 1994;120:799-805. 29. Streiner D. Clinimetrics vs. psychometrics: an unnecessary distinction. J Clin Epidemiol 2003 Dec;56(12):1142-5; discussion 1146-9. 30. Marx RG, Bombardier C, Hogg-Johnson S, et al. Clinimetric and psychometric strategies for development of a health measurement scale. J Clin Epidemiol 1999;52:105-111. 31. Ribera A, Permanyer-Miralda G, Alonso J, et al. Is psychometric scoring of the McNew Quality of Life after Myocardial Infarction questionnaire superior to the clinimetric scoring? A comparison of the two approaches. Qual Life Res 2006;15:357-365. 32. Beaton D, Wright JG, Katz J, et al. Development of the QuickDASH: comparison of three item- reduction approaches. J Bone Joint Surg Am 2005;87:1038-1046.